Nunzia Pharmaceutical Company filed its 10-K/A on Mar 29, 2022 for the period ending Dec 31, 2020. In this report its auditor, B F Borgers CPA PC, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.003 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 1.3M | |
+25.73% | 661B | |
+26.74% | 566B | |
-6.51% | 352B | |
+20.44% | 332B | |
+3.25% | 283B | |
+13.47% | 231B | |
+4.74% | 200B | |
-9.49% | 195B | |
-5.08% | 145B |
- Stock Market
- Equities
- NUNZ Stock
- News Nunzia Pharmaceutical Company
- Nunzia Pharmaceutical Company Auditor Raises 'Going Concern' Doubt